Amgen International Inc is categorized under Drug Brokers in Newbury Park, CA and active since 1989.
Amgen International Inc was established in 1989, and today employs 1 to 4, earning $50.000.000 to $99.999.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Madhavan Balachandrian at the company’s headquarters by writing to 1 Amgen Center Drive, Newbury Park, California CA 91320 or by phoning (805) 447-1000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Amgen International Inc |
| Contact Person: | Madhavan Balachandrian |
| Address: | 1 Amgen Center Drive, Newbury Park, California 91320 |
| Phone Number: | (805) 447-1000 |
| Website Address: | amgen.com |
| Annual Revenue (USD): | $50.000.000 to $99.999.999 |
| Founded: | 1989 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Drug Brokers |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Amgen International Inc was started in 1989 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000.000 to $99.999.999 per annum.
Feel free to contact Madhavan Balachandrian for inquiries that concern Amgen International Inc by calling the company number (805) 447-1000, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Amgen International Inc can be found at the coordinates 34.191857,-118.919297 as well as the street address 1 Amgen Center Drive in Newbury Park, California 91320.
For its online presence, you may visit Amgen International Inc’s website at amgen.com and engage with its social media outlets through on Twitter and on Facebook.